Impact of nucleos(t)ide analogues on quality of life in patients with chronic hepatitis B

Impact of nucleos(t)ide analogues on quality of life in patients with chronic hepatitis B

ObjectiveTo investigate the impact of treatment with nucleos(t)ide analogues on quality of life (QoL) in patients with chronic hepatitis B (CHB), as well as proper nursing measures. MethodsA total of 102 CHB patients who were treated in Department of Infectious Diseases, Nanfang Hospital, Southern M...

Full description

Bibliographic Details
Main Authors:	ZHONG Chunxiu, CAI Shaohang, YIN Junhua
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2016-11-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=7806

Similar Items

Effect of nucleos(t)ide analogue on serum HBsAg level in chronic hepatitis B patients: A 3-years study
by: Zhidan Zheng, et al.
Published: (2020-02-01)

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
by: Sang Kyung Jung, et al.
Published: (2015-03-01)

Renal safety in chronic hepatitis B patients treated with nucleos(t)ide analogues
by: NING Ling, et al.
Published: (2016-05-01)

Clinical effect of nucleos(t)ide analogues in treatment of acute exacerbation of chronic hepatitis B
by: RUAN Jianwen
Published: (2019-06-01)

Criteria for withdrawal of nucleos(t)ide analogues and their clinical significance in treatment of chronic hepatitis B
by: CHEN Hemin, et al.
Published: (2016-07-01)

Research advances in drug resistance to nucleos(t)ide analogues in treatment of chronic hepatitis B
by: FAN Xiu
Published: (2015-04-01)

Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
by: Luisa Roade, et al.
Published: (2021-02-01)

Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
by: E K Ibragimov, et al.
Published: (2019-02-01)

Influencing factors for compliance with antiviral therapy with nucleos(t)ide analogues in patients with chronic hepatitis B
by: WU Xiaofeng
Published: (2019-10-01)

Predictors of sustained virologic response after discontinuation of nucleos(t)ide analog treatment for chronic hepatitis B
by: Jie Peng, et al.
Published: (2015-01-01)

Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients.
by: Eun Ju Cho, et al.
Published: (2015-01-01)

Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patients
by: Ching-Chung Lin, et al.
Published: (2016-01-01)

Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
by: Margarita Papatheodoridi, et al.
Published: (2020-02-01)

Influence of interferon and nucleos(t)ide analogues on HBV cccDNA and functional cure of chronic hepatitis B
by: CHEN Jieliang
Published: (2019-06-01)

Research progress in combination therapy with pegylated interferon and nucleos(t)ide analogues in treatment of chronic hepatitis B
by: YU Yiqi, et al.
Published: (2015-09-01)

Kushenin Combined with Nucleos(t)ide Analogues for Chronic Hepatitis B: A Systematic Review and Meta-Analysis
by: Zhe Chen, et al.
Published: (2015-01-01)

48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients
by: Li Gao, et al.
Published: (2020-05-01)

Efficacy of peginterferon α-2a in treatment of chronic hepatitis B resistant to multiple nucleos(t)ide analogues
by: YANG Long, et al.
Published: (2016-04-01)

Current status of the research on low-level viremia in chronic hepatitis B patients receiving nucleos(t)ide analogues
by: LU Fengming
Published: (2021-06-01)

The Yin and the Yang of Treatment for Chronic Hepatitis B—When to Start, When to Stop Nucleos(t)ide Analogue Therapy
by: Samuel Hall, et al.
Published: (2020-08-01)

Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta‐Analysis
by: Nathan Ford, et al.
Published: (2018-10-01)

A Meta-Analysis of the Efficacy of Interferon Monotherapy or Combined with Different Nucleos(t)ide Analogues for Chronic Hepatitis B
by: Jialing Zhou, et al.
Published: (2016-07-01)

TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in China
by: Mingxing Huang, et al.
Published: (2017-01-01)

Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy
by: Jin Shang, et al.
Published: (2021-04-01)

Effects of nucleos(t)ide analogues on estimated glomerular filtration rate and serum creatinine level in patients with chronic hepatitis B
by: XU Yong, et al.
Published: (2016-02-01)

Change in HBsAg quantification after HBV DNA negative conversion in chronic hepatitis B patients treated with nucleos(t)ide analogues
by: ZHOU Youqian, et al.
Published: (2019-05-01)

Chinese Consensus on Antiviral Treatment of Chronic Hepatits B Patients with Nucleos(t)ide Analogues
by: Cheng Jun
Published: (2013-06-01)

Prevalence of Potential Resistance Related Variants Among Chinese Chronic Hepatitis B Patients Not Receiving Nucleos(T)ide Analogues
by: Qian F, et al.
Published: (2020-07-01)

Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review
by: Mohamed A Abd El Aziz, et al.
Published: (2020-05-01)

An expert consensus for the adjustment of treatment strategies in patients with chronic hepatitis B treated with non-first-line nucleos(t)ide analogues
by: The Hepatitis Group, Chinese Society of Hepatology, Chinese Medical Association; Chinese Journal of Hepatology
Published: (2019-06-01)

Nucleos(t)ide Analogue Treatment Cessation in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients: A Retrospective Single-center Study
by: Figen SARIGÜL, et al.
Published: (2020-12-01)

NEW METHOD FOR DETERMINING HEPATITIS B VIRUS RESISTANCE MUTATIONS M204I/V TO NUCLEOS(T)IDE ANALOGUES IN PATIENTS WITH CHRONIC HEPATITIS B
by: E. A. Elpaeva, et al.
Published: (2015-12-01)

Efficacy and Safety of Tenofovir for Chronic Hepatitis B Patients After Suboptimal Virological Response to Other Nucleos(t)ide Analogues Treatment
by: Kwei-Ming Chen, et al.
Published: (2016)

Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis.
by: Mao-Bing Chen, et al.
Published: (2019-01-01)

Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B.
by: Melanie Maier, et al.
Published: (2013-01-01)

48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse
by: Wen-xiong Xu, et al.
Published: (2018-01-01)

Long-term Nucleos(t)ides Analogues for Chronic Hepatitis B Improve Liver and Spleen Size: A Noninvasive Sonographic Study
by: Ruei-Hsin Chang, et al.
Published: (2017-09-01)

Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: A head-to-head study
by: Shu Yu, et al.
Published: (2014-01-01)

Stopping nucleos(t)ide analog treatment in chronic hepatitis B — Who and when?
by: Suzette Grace R. Kho-Herman, et al.
Published: (2017-09-01)

Long-Term Nucleos(t)ide Analogues Therapy for Adults With Chronic Hepatitis B reduces the Risk of Long-Term Complications: a meta-analysis
by: Ren Hong, et al.
Published: (2011-02-01)